Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Pfizer licenses new Genedata platform
March 2018
SHARING OPTIONS:

BASEL, Switzerland—February saw Pfizer Inc. license the Genedata Bioprocess enterprise platform from software solutions provider Genedata. Pfizer has been utilizing the Genedata Biologics platform since 2014, and integrating the two platforms will create a centralized data repository for research and development units, with better data tracking and analysis. Genedata Bioprocess is a first-in-class, off-the-shelf enterprise software solution offering fully integrated workflow support for large-molecule development and CMC. It can be operated alone or integrated with Genedata Biologics, and is a modular system that offers support from cell line development and upstream/downstream process development to formulation and analytical development.
 
“We are very pleased to see Pfizer adopting Genedata Bioprocess,” said Dr. Othmar Pfannes, CEO of Genedata. “This validates our strategy of developing a fully integrated workflow management platform that facilitates seamless R to D handovers of development candidates, samples, and associated data. In addition, a shared platform across R&D leads to substantial efficiency gains and cost savings.”

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.